Skip to Content

Join the 'Pediatric Growth Hormone Deficiency' group to help and get support from people like you.

Pediatric Growth Hormone Deficiency News

Growth Spurts Can Throw Off Teen Boys' Strut

Posted 20 May 2016 by Drugs.com

FRIDAY, May 20, 2016 – Growth spurts can affect teen boys' coordination and knock the swagger right out of their stride, a new study reveals. "A sudden increase in height affects the body's ability to control established motor skills, such as walking," said lead author Maria Cristina, of the University of Bologna, Italy. The study included 88 boys who were 15 years old. Those with growth spurts – defined as a height increase of more than 3 centimeters (1.2 inches) over three months – had a more awkward gait than those with steady growth, the researchers found. "Adolescents tend to show previous control of the body when growing up, but the motor control behavior is organized on the body's dimensions. Following a growth spurt, the body needs time to adjust to changes to the periphery, during which time a teenager may walk awkwardly, while teenagers who grow steadily are able to handle ... Read more

Related support groups: Pediatric Growth Hormone Deficiency, Foot Care

Short Boys Three Times More Likely to Get Growth Hormone: Study

Posted 16 Jun 2015 by Drugs.com

TUESDAY, June 16, 2015 – Short boys are much more likely than short girls to receive growth hormones, a new study finds. Researchers examined the medical records of more than 283,000 children and teens in the United States and found that short boys were up to three times more likely than short girls to receive recombinant human growth hormone treatment. Specifically, males accounted for 74 percent of patients who received the hormone to treat idiopathic short stature – shortness due to an unknown cause. Among patients who received the hormone for any diagnoses, 66 percent were male. The biggest gender differences in treatment occurred around puberty, when less time remains to correct poor growth in children, the researchers noted. The findings were published online June 9 in the journal Scientific Reports. "Growth is an important sign of child health, so growth failure merits equal ... Read more

Related support groups: Nutropin, Humatrope, Genotropin, Pediatric Growth Hormone Deficiency, Nutropin AQ, Serostim, Saizen, Norditropin, Omnitrope, Somatropin, Growth Retardation, Tev-Tropin, Norditropin Nordiflex, HumatroPen, Zomacton, Zorbtive, Growth Hormone Reserve Test, Nutropin Depot, Accretropin, Norditropin FlexPro

Children Prescribed Growth Hormone May Face Stroke Risk Later: Study

Posted 13 Aug 2014 by Drugs.com

WEDNESDAY, Aug. 13, 2014 – Children who are prescribed human growth hormone may be at greater risk of a stroke in early adulthood than their peers are, a new study suggests. While the study raises important questions about the safety of human growth hormone treatments, the study's French researchers encouraged parents to discuss the pros and cons of treatment with their child's physician. "For children and adolescents currently on growth hormone treatment, the treatment should not be stopped, but the doctor prescribing the treatment should be consulted," said study author Dr. Joel Coste, head of the biostatistics and epidemiology unit at Hotel Dieu at the University of Paris. One expert agreed that the finding should give parents pause. "The study represents a kind of yellow light that should make people stop and think about [the potential risks]," said Dr. Rebecca Ichord, director of ... Read more

Related support groups: Nutropin, Humatrope, Genotropin, Pediatric Growth Hormone Deficiency, Nutropin AQ, Serostim, Saizen, Norditropin, Somatropin, Omnitrope, Growth Retardation, Tev-Tropin, Norditropin Nordiflex, Norditropin FlexPro, Zorbtive, Nutropin Depot, Accretropin, HumatroPen

Novo Nordisk Receives FDA Approval for Norditropin FlexPro for Growth Hormone Treatment

Posted 10 Mar 2010 by Drugs.com

PRINCETON, N.J., March 3, 2010 /PRNewswire/ – Novo Nordisk announced today that the U.S. Food and Drug Administration (FDA) has approved Norditropin FlexPro (somatropin [rDNA origin] injection), a pre-filled injection pen to be used by children and adults with growth hormone disorders. It will be available in the second quarter. Norditropin FlexPro has a user friendly design which makes it easy to learn and use, and an audible click that confirms that the medication has left the pen. Norditropin FlexPro requires no reconstitution and no loading of cartridges. Norditropin FlexPro is available in 5 mg/1.5 mL, 10 mg/1.5 mL and 15 mg/1.5 mL pens. After first use, the 5 mg/1.5 mL and 10 mg/1.5 mL pens may be left at room temperature for up to three weeks without risk of spoilage. In a study designed to evaluate the usability of the product, 100 percent of patients found it easy to learn ... Read more

Related support groups: Adult Human Growth Hormone Deficiency, Pediatric Growth Hormone Deficiency, Norditropin, Somatropin, Turner's Syndrome, Norditropin Nordiflex, Noonan's Syndrome

Ask a Question

Further Information

Related Drug Support Groups

Nutropin, Humatrope, Genotropin, Nutropin AQ, Saizen, Norditropin, Omnitrope, somatropin, Tev-Tropin, view more... HumatroPen, Zomacton, Norditropin Nordiflex, Norditropin FlexPro, Nutropin Depot, somatrem, Protropin, Accretropin